T. Rowe Price Associates
SWAV

T. Rowe Price Associates’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

T. Rowe Price Associates’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-598,200
Closed -$195M – 3070
2024
Q1 		$195M Sell
598,200
-186,769
-24% -$45.9M 0.02% 424
2023
Q4 		$150M Sell
784,969
-452,772
-37% -$85.6M 0.02% 469
2023
Q3 		$246M Buy
1,237,741
+146,691
+13% +$34.7M 0.04% 351
2023
Q2 		$311M Sell
1,091,050
-303,717
-22% -$84.3M 0.04% 319
2023
Q1 		$302M Buy
1,394,767
+382,374
+38% +$74.5M 0.05% 313
2022
Q4 		$208M Sell
1,012,393
-784,628
-44% -$198M 0.03% 372
2022
Q3 		$500M Sell
1,797,021
-1,417,657
-44% -$361M 0.08% 225
2022
Q2 		$615M Buy
3,214,678
+627,712
+24% +$111M 0.08% 248
2022
Q1 		$536M Sell
2,586,966
-490,286
-16% -$80.8M 0.05% 317
2021
Q4 		$549M Sell
3,077,252
-142,722
-4% -$28.1M 0.05% 336
2021
Q3 		$663M Sell
3,219,974
-76,720
-2% -$15.1M 0.06% 300
2021
Q2 		$625M Sell
3,296,694
-642,323
-16% -$105M 0.06% 306
2021
Q1 		$513M Buy
3,939,017
+1,458,245
+59% +$175M 0.05% 329
2020
Q4 		$257M Buy
2,480,772
+150,031
+6% +$13M 0.03% 459
2020
Q3 		$177M Sell
2,330,741
-243,105
-9% -$13.8M 0.02% 512
2020
Q2 		$122M Sell
2,573,846
-91,127
-3% -$3.75M 0.02% 581
2020
Q1 		$88.4M Sell
2,664,973
-1,365,237
-34% -$54.2M 0.01% 606
2019
Q4 		$177M Buy
4,030,210
+418,013
+12% +$15.4M 0.02% 507
2019
Q3 		$108M Buy
3,612,197
+1,554,422
+76% +$66M 0.02% 610
2019
Q2 		$114M Buy
2,057,775
+162,999
+9% +$7.92M 0.02% 611
2019
Q1 		$61.4M Buy
+1,894,776
New +$62.9M 0.01% 793

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

T. Rowe Price Associates's SWAV Position: Q2 2024 in Review

T. Rowe Price Associates sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 598,200 shares — an estimated $195M sold.

T. Rowe Price Associates first reported a position in SWAV in Q1 2019 and held it in 21 quarters. The position peaked at $663M in Q3 2021. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • T. Rowe Price Associates reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 598,200 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $195M.
  • T. Rowe Price Associates first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2019 and held it in 21 quarters.
  • T. Rowe Price Associates's Shockwave Medical, Inc. Common Stock position peaked at $663M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.